Abdominal obesity and its metabolic complications: Implications for the risk of ischaemic heart disease

Coronary Artery Disease

Volumn 9, Issue 8, 1998, Pages 473-481

  Lamarche, Benoît ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Apolipoprotein B; Cholesterol; Dyslipidemias; Epidemiology; Fat distribution; Insulin resistance; Obesity; Risk factors; Small dense LDL; Visceral obesity

Indexed keywords

APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMEN; ADIPOSE TISSUE; BODY FAT; CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; GENETIC HETEROGENEITY; HEALTH HAZARD; HUMAN; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPOPROTEIN BLOOD LEVEL; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; RISK FACTOR; STATISTICAL ANALYSIS; VISCERA;

EID: 0031771245     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199809080-00002     Document Type: Review

References (58)

1. Bray GA. Complications of obesity. Ann Intern Med 1985; 103:1052-1062.
2. Kissebah AH, Krakower GR. Regional adiposity and morbidity. Am J Physiol 1994; 74:761-811. This very comprehensive and detailed review covers all aspects of adipose tissue distribution-related health hazards and metabolic complications, from the clinical and epidemiological viewpoint to the cellular and physiological perspective.
3. Vague J. [Sexual differentiation, a factor affecting the forms of obesity]. Presses Médicales 1947; 30:339-340.
4. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54:254-260.
5. Evans DJ, Hoffman RG, Kalkhoff RK, Kissebah AH. Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 1984; 33:68-75.
6. Peiris A, Mueller RA, Smith GA, Struve MF, Kissebah AH. Splanchnic insulin metabolism in obesity: Influence of body fat distribution. J Clin Invest 1986; 78:1648-1657.
7. Ohlson LO, Larsson B, Svardsudd K, Welin L, Eriksson H, Wilhelmsen L, et al. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985; 34:1055-1058.
8. Després JP, Ross R, Lemieux S: Imaging techniques applied to the measurement of human body composition. In: Roche A, Heymsfield SB, Lohman T (editors): Human body composition. Champaign, Il: Human Kinetics; 1996. pp. 149-166.
9. Després JP, Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1993; 6:137-159.
10. Després JP, Nadeau A, Tremblay A, Ferland M, Moorjani S, Lupien PJ, et al. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989; 38:304-309.
11. Pouliot MC, Després JP, Nadeau A, Moorjani S, Prud'Homme D, Lupien PJ, et al. Visceral obesity in men. Associations with glucose tolerance, plasma insulin and lipoprotein levels. Diabetes 1992; 41:826-834.
12. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Kotani K, Tokunaga K. Pathophysiology and pathogenesis of visceral fat obesity. Obesity Res 1995; 3 (suppl 2):187S-194S.
13. Park KS, Rhee BD, Lee KU, Kim SY, Lee HK, Koh CS, et al. Intraabdominal fat is associated with decreased insulin sensitivity in healthy young men. Metabolism 1991; 40:600-603.
14. Després JP, Lemieux S, Lamarche B, Prud'Homme D, Moorjani S, Brun LD, et al. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications. Int J Obes 1995; 19 (suppl 1): S76-86.
15. Peiris AN, Mueller RA, Struve MF, Smith GA, Kissebah AH. Relationship of androgenic activity to splanchnic insulin metabolism and peripheral glucose utilization in premenopausal women. J Clin Endocrinol Metab 1987; 64:162-169.
16. Rebuffé-Scrive M, Andersson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots in nonobese men and women. Metabolism 1989; 38:453-458.
17. Rebuffé-Scrive M, Andersson B, Olbe L, Björntorp P. Metabolism of adipose tissue in intraabdominal depots in severely obese men and women. Metabolism 1990; 39:1021-1025.
18. Björntorp P. 'Portal' adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990; 10: 493-496.
19. Boyko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY. Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men. Diabetes 1996; 45:1010-1015. The development of visceral adiposity in relation to fasting and stimulated insulin and C-peptide levels was investigated prospectively in a sample of Japanese Americans. It is suggested that greater insulin resistance and reduced insulin secretion may precede visceral fat accumulation.
20. Després JP, Tremblay A, Pérusse L, Leblanc C, Bouchard C. Abdominal adipose tissue and serum HDL-cholesterol: association independent from obesity and serum triglyceride concentration. Int J Obes 1988; 12:1-13.
21. Peiris AN, Sothmann MS, Hoffmann RG, Hennes MI, Wilson CR, Gustafson AB, et al. Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 1989; 110:867-872.
22. Després JP, Moorjani S, Lupien PJ, Tremblay A, Nadeau A, Bouchard C. Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arterioscler Thromb Vasc Biol 1990; 10:497-511.
23. Lewis GF. Fatty acid regulation of very low density lipoprotein (VLDL) production. Curr Opin Lipidol 1997; 8:146-153.
24. Lemieux S, Prud'Homme D, Moorjani S, Tremblay A, Bouchard C, Lupien, et al. Do elevated levels of abdominal visceral adipose tissue contribute to age-related differences in plasma lipoprotein concentrations in men? Atherosclerosis 1995; 118:155-164.
25. Shen MM, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low density lipoproteins in normal humans subjects. J Lipid Res 1981; 22:236-244.
26. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982; 23: 97-104.
27. Austin MA, Hokanson JE, Brunzell JD: Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994; 5:395-403.
28. Tchernof A, Lamarche B, Nadeau A, Moorjani S, Labrie F, Lupien PJ, et al. The dense LDL phenotype: association with plasma lipoprotein levels, visceral obesity and hyperinsulinemia in men. Diabetes Care 1996; 19:629-637.
29. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991; 32:1741-1753.
30. Haffner SM. The insulin resistance syndrome revisited. Diabetes Care 1996; 19:275-277.
31. Nakamura T, Tokunaga K, Shimomura I, Nishida M, Yoshida S, Kotani K, et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. Atherosclerosis 1994; 107:239-246. Levels of visceral fat were higher in patients with CAD compared with healthy controls matched for sex, age and body mass index. These cross-sectional findings provided further evidence that visceral fat accumulation may play an important role in the occurrence of CAD, regardless of obesity.
32. Zamboni M, Armellini F, Sheiban I, De Marchi M, Todesco T, Bergamo-Andreis IA, et al. Relation of body fat distribution in men and degree of coronary narrowings in coronary artery disease. Am J Cardiol 1992; 70:1135-1138. Visceral adipose tissue accumulation was found to be one of the most significant predictors of angiographically demonstrated CAD in multivariate analysis, suggesting that visceral fat may be a potent cardiovascular risk factor.
33. Fujimoto W, Boyko E, Chen KW, Leonetti D, Newell L, Wahl P. Visceral adiposity, glycemia and high blood pressure increase the risk of coronary heart disease. Diabetes 1997; 46 (suppl 1):108A.
34. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986; 256:2823-2828.
35. Manninen V, Tenkanen L, Koshinen P, Huttunen JK, Mänttäri M, Heinonen OP, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 1992; 85:37-45.
36. Dagenais GR, Robitaille NM, Lupien PJ, Christen A, Gingras S, Moorjani S, et al. First coronary heart disease event rates in relation to major risk factors: Québec cardiovascular study. Can J Cardiol 1990; 6:274-280.
37. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Prevalence of dyslipidemic phenotypes in ischemic heart disease (prospective results from the Québec Cardiovascular Study). Am J Cardiol 1995; 75:1189-1195.
38. Lamarche B, Moorjani S, Lupien PJ, Cantin B, Bernard PM, Dagenais GR, et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Québec Cardiovascular Study. Circulation 1996; 94:273-278.
39. Lamarche B, Després JP, Moorjani S, Cantin B, Dagenais GR, Lupien PJ. Triglycerides and HDL-cholesterol as risk factors for ischemic heart disease. Results from the Québec Cardiovascular Study. Atherosclerosis 1996; 119:235-245.
40. Lamarche B, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP. Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Arterioscler Thromb Vasc Biol 1997; 17:1098-1105.
41. Sniderman AD, Shapiro S, Marpole D, Skinner B, Teng B, Kwiterovich PO Jr. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human low density (beta) lipoproteins]. Proc Natl Acad Sci USA 1980; 77: 604-608.
42. Sniderman AD, Cianflone K. Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias. Clin Chem 1996; 42:489-491.
43. Lamarche B, Tchernof A, Dagenais GR, Cantin B, Lupien PJ, Després JP. Small, dense LDL particles and the risk of ischemic heart disease. Prospective results from the Québec Cardiovascular Study. Circulation 1997; 95:69-75.
44. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willet WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260:1917-1921.
45. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996; 276:875-881.
46. Després JP, Lamarche B, Mauriège P, Cantin B, Dagenais GR, Moorjani S, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996; 334:952-957.
47. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG, Walker MK, Alberti, et al. Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol 1996; 144:224-234. Serum insulin concentrations were associated with an increased risk of IHD in a sample of 5550 men followed up for 11.5 years in both univariate and multivariate analysis, consistent with the hypothesis that hyperinsulinemia may be atherogenic.
48. Gaudet D, Vohl MC, Perron P, Tremblay G, Gagné C, Lesiège D, et al. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation 1998; 97:871-877. The most substantial increase in the risk of angiographically determined CAD patients with familial hypercholesterolemia was observed among abdominally obese and insulin-resistant individuals. This study provides support for the notion that the hyperinsulinemic-insulin-resistant state of abdominal obesity is a powerful predictor of CAD, even in a population at very high risk, such as patients with familial hypercholesterolemia.
49. Brown MS, Goldstein JL. A receptor-mediated for pathway for cholesterol homeostasis. Science 1986; 232:34-47.
50. Phillips AN, Davey Smith G: How independent are 'independent' effects? Relative risk estimation when correlated exposures are measured imprecisely. J Clin Epidemiol 1991; 44:1223-1231.
51. Lemieux S, Prud'Homme D, Tremblay A, Bouchard C, Després JP. Anthropometric correlates to changes in visceral adipose tissue over 7 years in women. Int J Obes 1996; 20:618-624. It is reported that changes in the waist circumference, as opposed to changes in the waist/hip ratio, represent a better anthropometric predictor of changes in visceral adipose tissue accumulation that occur with age.
52. Lemieux S, Prud'Homme D, Bouchard C, Tremblay A, Després JP. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 1996; 64:685-693. This study provides reference values of waist circumference corresponding to critical levels of visceral adipose tissue above which metabolic complications are most likely to occur. Although the relationship between the waist circumference and visceral adipose tissue accumulation is age-specific, it does not appear to be affected either by sex or by the degree of obesity.
53. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994; 73:460-468.
54. Lemieux S, Prud'Homme D, Bouchard C, Tremblay A, Després JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr 1993; 58:463-467.
55. Conway JM, Yanovski SZ, Avila NA, Hubbard VS. Visceral adipose tissue differences in black and white women. Am J Clin Nutr 1995; 61:765-771.
56. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes 1997; 46:456-462.
57. Lemieux S. Genetic susceptibility to visceral obesity and related clinical implications. Int J Obes 1997; 21:831-838.
58. Després JP: The insulin resistance-dyslipidemic syndrome of visceral obesity: effects on patients' risk. Obesity Res 1998; 6 (suppl 1):85-175.